Skip to main navigation Skip to search Skip to main content

Favorable Response of Advanced Superior Sulcus Non-Small Cell Lung Carcinoma to Gefitinib for 11 years complicated by Interval Development of Small Cell Carcinoma of the Lung.

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalMarshall Journal of Medicine
DOIs
StatePublished - 1800

Keywords

  • Gefitinib
  • Lung cancer

Disciplines

  • Medicine and Health Sciences

Cite this